Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Galderma Group AG's Enterprise Value is $26,822 Mil.
Galderma Group AG does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Jun. 2024. Therefore, GuruFocus does not calculate Galderma Group AG's EV-to-EBIT at this moment.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Galderma Group AG's Enterprise Value is $26,822 Mil.
Galderma Group AG does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Jun. 2024. Therefore, GuruFocus does not calculate Galderma Group AG's EV-to-EBITDA at this moment.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Galderma Group AG's Enterprise Value is $26,822 Mil.
Galderma Group AG does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Jun. 2024. Therefore, GuruFocus does not calculate Galderma Group AG's EV-to-Revenue at this moment.
Galderma Group AG Enterprise Value Historical Data
The historical data trend for Galderma Group AG's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Galderma Group AG Enterprise Value Chart
Galderma Group AG Annual Data
Trend
Enterprise Value
Galderma Group AG Semi-Annual Data
Jun23
Jun24
Enterprise Value
-
-
Competitive Comparison of Galderma Group AG's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galderma Group AG's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Galderma Group AG's Enterprise Value falls into.
Galderma Group AG Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Galderma Group AG's Enterprise Value for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galderma Group AG (OTCPK:GALDY) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
Galderma Group AG Enterprise Value Related Terms
Thank you for viewing the detailed overview of Galderma Group AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GALDY has been successfully added to your